Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 3

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  limfocyty CD8 plus
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Regulatory T cells are heterogeneous with sub-populations which differ from each other in their phenotype, immune inhibitory mechanisms and functioning. These cells are responsible for regulation of immune response and play a leading role in developing immune tolerance through active suppression. Suggested functions for regulatory T cells include: prevention of autoimmune diseases by maintaining self-tolerance, oral tolerance and, moreover, suppression of allergy and pathogen-induced immunopathology. CD4⁺ regulatory cells, such as Treg, Tr1 and Th3, are the most comprehensively studied and characterized regulatory lymphocytes; however, in recent years substantial progress has been made in the phenotypic and functional characterization of CD8⁺ regulatory cells. These cells can be divided into two general groups: natural and induced lymphocytes. Natural regulatory cells develop in the thymus, constitute a stable lineage, while their induced counterparts are generated under experimental conditions and may or may not have stable phenotypes. Both types of these cells can be subdivided into several phenotypic groups. The author reviews the current state of knowledge concerning the best-characterized human and murine CD8⁺ regulatory lymphocytes, i.e., CD8⁺ CD25⁺ Foxp3⁺, CD8⁺ Foxp3⁺, CD8⁺ CD122+ and CD8⁺ CD28⁻ cells. This paper focuses on aspects concerning the phenotype and phenotypic markers of these cells, as well as their immune inhibitory mechanisms.
The aim of the research was to determine the influence of a synthetic immunomodulator methisoprinol applied in ovo as a 10% solution in doses of 5 mg per egg (group I) and 20 mg of active substance per egg (group II) on the 26th day of incubation on T-lymphocyte subpopulations in the blood and spleen of 5-day-old turkeys hatched from the treated eggs. The control group (group III) were turkeys hatched from eggs in standard hatchery conditions (without in ovo injections). The percentage of T-lymphocyte subpopulations was determined by flow cytometry using specific monoclonal anti-T CD3⁺, CD4⁺ and CD8⁺antibodies and an EPICS XL apparatus. It was demonstrated that methisoprinol applied in ovo in doses of 5 mg per egg stimulated non-specific mechanisms of humoral immunity in 5-day-old turkey poults hatched from the treated eggs, which resulted in a higher percentage of CD3⁺ and CD4⁺ T-lymphocytes in their blood and spleen. Methisoprinol applied in ovo in doses of 20 mg per egg stimulated mainly non-specific mechanisms of cellular immunity in 5-day-old turkey poults hatched from the treated eggs, as evidenced by a higher percentage of CD8⁺ T-lymphocytes in the spleen.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.